Abstract:Background: Hereditary spastic paraplegia (HSP) constitutes a group of clinically and genetically rare neurodegenerative diseases characterized by progressive corticospinal tract degeneration. The phenotypes and genotypes of HSP are still expanding. In this study, we aimed to analyse the differential diagnosis, clinical features, and genetic distributions of a Chinese HSP patients in a 14-year cohort and to improve our understanding of the disease.Methods: The clinical data of patients with a primary diagnosis of HSP at the initial visit to the Department of the Neurology, Peking University Third Hospital, from 2008 to 2022 were retrospectively collected. Next-generation sequencing gene panels (NGS) combined with a multiplex ligation-amplification assay (MLPA) were conducted. Epidemiological and clinical features and candidate variants in HSP-related genes were analyzed and summarized.Results: 54 cases (probands from 25 different pedigrees and 29 sporadic cases) from 95 patients with a primary diagnosis of HSP were finally confirmed to have a clinical diagnosis of HSP based on clinical criteria, including their clinical findings, family history and long-term follow-up. Earlier disease onset was associated with longer diagnostic delay and longer disease duration and was associated with a lower risk of loss of ability to walk independently. In addition, 20 candidate variants in reported HSP-related genes were identified in these clinically diagnosed HSP patients, including variants in SPAST, ALT1, WASHC5, SPG11, B4GALNT1, and REEP1. The genetic diagnostic rate in these 54 patients was 35.18%.Conclusion: Hereditary spastic paraplegia has high clinical and genetic heterogeneity and is prone to misdiagnosis. Long-term follow-up and genetic testing can partially assist in diagnosing HSP. Our study summarized the clinical features of Chinese HSP patients in a 14-year cohort, expanded the genotype spectrum, and improved our understanding of the disease.

Genetic, clinical and neuroimaging profiles of sporadic and autosomal recessive hereditary spastic paraplegia cases in Chinese

Mutation and Clinical Characteristics of Autosomal-Dominant Hereditary Spastic Paraplegias in China

Three Novel Mutations of the Spastin Gene in Chinese Patients with Hereditary Spastic Paraplegia

Analysis on Mutations of Spastin, Atlastin and Paraplegin Genes in Chinese Patients with Hereditary Spastic Paraplegia

Exon 8-17 Deletions of Spast in A Chinese Family with Hereditary Spastic Paraplegia: A Case Report and Literature Review

Receptor Expression-Enhancing Protein 1 Gene (SPG31) Mutations Are Rare in Chinese Han Patients with Hereditary Spastic Paraplegia.

Genetic Analysis of SPG4 and SPG3A Genes in a Cohort of Chinese Patients with Hereditary Spastic Paraplegia.

Molecular genetics study of hereditary spastic paraplegia accompanied by distal amyotrophy-an update

[Spastin Gene Mutation in Chinese Patients with Hereditary Spastic Paraplegia].

[The Clinical Characteristics of a Pedigree with Incompletely Penetrated Autosomal Dominant Hereditary Spastic Paraplegia and Its Exclusion Analysis of Genetic Loci].

Clinical Features and Genetic Spectrum in Chinese Patients with Recessive Hereditary Spastic Paraplegia

[Gene Screening in Five Chinese Families with Hereditary Spastic Paraplegia with Thin Corpus Callosum].

Characteristics of Clinical and Spastin Gene Mutation in a Family with Hereditary Spastic Paraplegia

A Novel Candidate Locus on Chromosome 11P14.1-P11.2 for Autosomal Dominant Hereditary Spastic Paraplegia

Expansion of the Phenotypic Spectrum of SPG6 Caused by Mutation in NIPA1.

Novel Mutations in the SPAST Gene Cause Hereditary Spastic Paraplegia.

Identification of Novel SPG11 Mutations in a Cohort of Chinese Families with Hereditary Spastic Paraplegia.

Chinese Families with Autosomal Recessive Hereditary Spastic Paraplegia Caused by Mutations in SPG11

Clinical features and genetic spectrum of Chinese patients with hereditary spastic paraplegia: A 14-year study

Mutations Analysis of SPG11 Gene in Chinese Han Patients with Hereditary Spastic Paraplegia

Novel SPG11 Mutations in Chinese Families with Hereditary Spastic Paraplegia with Thin Corpus Callosum.